Beacon Investment Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.69M Sell
4,161
-20,699
-83% -$8.39M 0.07% 114
2025
Q1
$12.4M Sell
24,860
-8,867
-26% -$4.41M 0.58% 54
2024
Q4
$17.5M Sell
33,727
-1,756
-5% -$914K 0.76% 48
2024
Q3
$21.9M Sell
35,483
-579
-2% -$358K 0.91% 41
2024
Q2
$19.9M Sell
36,062
-1,552
-4% -$858K 0.86% 41
2024
Q1
$21.9M Sell
37,614
-2,007
-5% -$1.17M 0.94% 36
2023
Q4
$21M Sell
39,621
-11,497
-22% -$6.1M 0.96% 35
2023
Q3
$25.9M Buy
51,118
+3,122
+7% +$1.58M 1.27% 26
2023
Q2
$25M Buy
47,996
+18,712
+64% +$9.76M 1.15% 27
2023
Q1
$16.9M Sell
29,284
-5,654
-16% -$3.26M 0.82% 38
2022
Q4
$19.2M Buy
34,938
+3,880
+12% +$2.14M 0.99% 31
2022
Q3
$15.8M Buy
31,058
+1,638
+6% +$831K 0.87% 39
2022
Q2
$16M Buy
29,420
+4,187
+17% +$2.27M 0.83% 41
2022
Q1
$14.9M Buy
25,233
+662
+3% +$391K 0.64% 48
2021
Q4
$16.4M Buy
24,571
+12,157
+98% +$8.11M 0.64% 49
2021
Q3
$7.09M Buy
12,414
+4,829
+64% +$2.76M 0.29% 78
2021
Q2
$3.83M Buy
7,585
+377
+5% +$190K 0.15% 109
2021
Q1
$3.29M Buy
7,208
+1,157
+19% +$528K 0.14% 114
2020
Q4
$2.82M Buy
6,051
+771
+15% +$359K 0.13% 113
2020
Q3
$2.33M Buy
5,280
+405
+8% +$179K 0.12% 120
2020
Q2
$1.77M Buy
4,875
+2,500
+105% +$906K 0.1% 128
2020
Q1
$674K Buy
2,375
+840
+55% +$238K 0.05% 149
2019
Q4
$499K Hold
1,535
0.03% 173
2019
Q3
$447K Hold
1,535
0.04% 166
2019
Q2
$451K Hold
1,535
0.05% 151
2019
Q1
$420K Sell
1,535
-215
-12% -$58.8K 0.04% 161
2018
Q4
$392K Sell
1,750
-328
-16% -$73.5K 0.04% 176
2018
Q3
$507K Sell
2,078
-7
-0.3% -$1.71K 0.05% 160
2018
Q2
$432K Buy
2,085
+12
+0.6% +$2.49K 0.04% 170
2018
Q1
$428K Buy
2,073
+19
+0.9% +$3.92K 0.04% 168
2017
Q4
$390K Sell
2,054
-177
-8% -$33.6K 0.04% 169
2017
Q3
$422K Buy
+2,231
New +$422K 0.04% 193